186 related articles for article (PubMed ID: 33112208)
21. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
22. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic p53 and activated Bax regulate p53-dependent, transcription-independent neural precursor cell apoptosis.
Geng Y; Walls KC; Ghosh AP; Akhtar RS; Klocke BJ; Roth KA
J Histochem Cytochem; 2010 Mar; 58(3):265-75. PubMed ID: 19901272
[TBL] [Abstract][Full Text] [Related]
24. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma.
Wang CL; Wang JY; Liu ZY; Ma XM; Wang XW; Jin H; Zhang XP; Fu D; Hou LJ; Lu YC
Carcinogenesis; 2014 Jul; 35(7):1500-9. PubMed ID: 24445145
[TBL] [Abstract][Full Text] [Related]
26. The cytoplasmic side of p53's oncosuppressive activities.
Comel A; Sorrentino G; Capaci V; Del Sal G
FEBS Lett; 2014 Aug; 588(16):2600-9. PubMed ID: 24747877
[TBL] [Abstract][Full Text] [Related]
27. Stress-dependent Daxx-CHIP interaction suppresses the p53 apoptotic program.
McDonough H; Charles PC; Hilliard EG; Qian SB; Min JN; Portbury A; Cyr DM; Patterson C
J Biol Chem; 2009 Jul; 284(31):20649-59. PubMed ID: 19465479
[TBL] [Abstract][Full Text] [Related]
28. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.
Chipuk JE; Bouchier-Hayes L; Kuwana T; Newmeyer DD; Green DR
Science; 2005 Sep; 309(5741):1732-5. PubMed ID: 16151013
[TBL] [Abstract][Full Text] [Related]
29. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
30. HOPS: a novel cAMP-dependent shuttling protein involved in protein synthesis regulation.
Della Fazia MA; Castelli M; Bartoli D; Pieroni S; Pettirossi V; Piobbico D; Viola-Magni M; Servillo G
J Cell Sci; 2005 Jul; 118(Pt 14):3185-94. PubMed ID: 16014383
[TBL] [Abstract][Full Text] [Related]
31. Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53.
Kim IS; Kim DH; Han SM; Chin MU; Nam HJ; Cho HP; Choi SY; Song BJ; Kim ER; Bae YS; Moon YH
J Biol Chem; 2000 Jul; 275(30):23139-45. PubMed ID: 10930427
[TBL] [Abstract][Full Text] [Related]
32. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
Chen D; Yoon JB; Gu W
Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
[TBL] [Abstract][Full Text] [Related]
33. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
34. Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1.
Higashitsuji H; Higashitsuji H; Masuda T; Liu Y; Itoh K; Fujita J
J Biol Chem; 2007 May; 282(18):13716-25. PubMed ID: 17353187
[TBL] [Abstract][Full Text] [Related]
35. p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury.
Seth R; Yang C; Kaushal V; Shah SV; Kaushal GP
J Biol Chem; 2005 Sep; 280(35):31230-9. PubMed ID: 15983031
[TBL] [Abstract][Full Text] [Related]
36. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
37. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic localization of DGKζ exerts a protective effect against p53-mediated cytotoxicity.
Tanaka T; Okada M; Hozumi Y; Tachibana K; Kitanaka C; Hamamoto Y; Martelli AM; Topham MK; Iino M; Goto K
J Cell Sci; 2013 Jul; 126(Pt 13):2785-97. PubMed ID: 23606744
[TBL] [Abstract][Full Text] [Related]
39. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization.
Han MK; Song EK; Guo Y; Ou X; Mantel C; Broxmeyer HE
Cell Stem Cell; 2008 Mar; 2(3):241-51. PubMed ID: 18371449
[TBL] [Abstract][Full Text] [Related]
40. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
Joseph TW; Zaika A; Moll UM
FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
